• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成生长因子和生物标志物中期因子是一种肿瘤共享抗原。

The angiogenic growth factor and biomarker midkine is a tumor-shared antigen.

机构信息

Commissariat à l'Energie Atomique-Saclay, Institut de Biologie et Technologies, Service d'Ingénierie Moléculaire des Protéines, Gif-sur-Yvette, France.

出版信息

J Immunol. 2010 Jul 1;185(1):418-23. doi: 10.4049/jimmunol.0901014. Epub 2010 May 28.

DOI:10.4049/jimmunol.0901014
PMID:20511550
Abstract

The angiogenic factor Midkine (MDK) is overexpressed in various human malignant tumors, although its expression is low or undetectable in normal adult tissues. Its expression in tumors and its detection in plasma have been associated with poor disease outcome, whereas its blockade was found to contribute to tumor regression. By weekly stimulation of T lymphocytes harvested in HLA-A2 healthy donors, we derived CD8 T cell lines specific for several MDK peptides. The T cell response was mostly dominated by two nonamer peptides localized in the signal peptide and in the C-terminal part of the protein, as assessed by IFN-gamma ELISPOT and HLA-A2 tetramer labeling. Peptide-specific T cell lines recognized cells transfected with an MDK-encoded plasmid and tumor cell lines naturally expressing the MDK protein, but not untransfected cells. T cell presentation of the two MDK epitopes was found to be TAP dependent. Experiments performed in HLA-A2 transgenic mice demonstrated the capacity of the two identified CD8 T cell epitopes to elicit a cytotoxic response. Altogether, our data show that the secreted MDK protein is a candidate vaccine for multiple cancers.

摘要

血管生成因子中期因子(MDK)在各种人类恶性肿瘤中过度表达,尽管其在正常成人组织中的表达水平较低或无法检测到。其在肿瘤中的表达及其在血浆中的检测与疾病预后不良相关,而其阻断被发现有助于肿瘤消退。通过每周刺激 HLA-A2 健康供体中采集的 T 淋巴细胞,我们衍生出针对多种 MDK 肽的 CD8 T 细胞系。通过 IFN-γ ELISPOT 和 HLA-A2 四聚体标记评估,T 细胞反应主要由位于信号肽和蛋白质 C 末端的两个非肽决定,该反应主要由两个非肽决定,由位于信号肽和蛋白质 C 末端的两个非肽决定。鉴定的两个 CD8 T 细胞表位的 T 细胞呈递被发现依赖于 TAP。在 HLA-A2 转基因小鼠中进行的实验证明了这两个鉴定的 CD8 T 细胞表位具有引发细胞毒性反应的能力。总的来说,我们的数据表明分泌的 MDK 蛋白是多种癌症的候选疫苗。

相似文献

1
The angiogenic growth factor and biomarker midkine is a tumor-shared antigen.血管生成生长因子和生物标志物中期因子是一种肿瘤共享抗原。
J Immunol. 2010 Jul 1;185(1):418-23. doi: 10.4049/jimmunol.0901014. Epub 2010 May 28.
2
Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.通过CD8(+) T细胞释放粒细胞巨噬细胞集落刺激因子而非细胞溶解作用来检测自然加工且由HLA - A1呈递的黑色素瘤T细胞表位。
Clin Cancer Res. 1996 Jan;2(1):87-95.
3
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.乳腺癌患者的CD8 + 细胞毒性T淋巴细胞对HLA - A2限制性乳腺珠蛋白-A衍生表位的识别。
Breast Cancer Res Treat. 2004 Nov;88(1):29-41. doi: 10.1007/s10549-004-8918-1.
4
Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.含有凋亡黑素瘤细胞的树突状细胞可启动人类CD8+T细胞,以实现高效的肿瘤细胞裂解。
Cancer Res. 2000 Aug 15;60(16):4446-52.
5
The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.癌症/睾丸抗原的TAG家族在多种恶性肿瘤中广泛表达,并产生HLA - A2限制性表位。
J Immunother. 2008 Jan;31(1):7-17. doi: 10.1097/CJI.0b013e318159f797.
6
The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.HER2/neu衍生肽p654 - 662是一种在人类胰腺癌中被细胞毒性T淋巴细胞识别的肿瘤相关抗原。
Eur J Immunol. 1997 May;27(5):1115-23. doi: 10.1002/eji.1830270511.
7
Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.利用前列腺特异性抗原(PSA)寡表位肽产生针对前列腺特异性抗原的人细胞溶解T淋巴细胞系。
J Immunol. 1998 Sep 15;161(6):3186-94.
8
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.Her-2/neu衍生肽是由人肾癌细胞系和结肠癌细胞系表达的肿瘤相关抗原,并被体外诱导的特异性细胞毒性T淋巴细胞识别。
Cancer Res. 1998 Feb 15;58(4):732-6.
9
Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.卵巢肿瘤抗原角质层糜蛋白酶中免疫原性区域的定义。
Clin Cancer Res. 2005 May 1;11(9):3446-54. doi: 10.1158/1078-0432.CCR-04-2043.
10
Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.上皮癌中一种新型细胞毒性T淋巴细胞识别抗原系统——叶酸结合蛋白的疫苗学意义
Clin Cancer Res. 1999 Dec;5(12):4214-23.

引用本文的文献

1
Metabolic reprogramming of arachidonic acid in clear cell renal carcinoma promotes an immunosuppressive microenvironment by activating MDK signaling pathway.透明细胞肾细胞癌中花生四烯酸的代谢重编程通过激活MDK信号通路促进免疫抑制微环境。
Clin Exp Med. 2025 Aug 13;25(1):291. doi: 10.1007/s10238-025-01807-8.
2
EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis.表皮生长因子受体III型变异体(EGFRvIII)阳性的胶质母细胞瘤通过c-Fos-膜联蛋白DK(MDK)-低密度脂蛋白受体相关蛋白1(LRP1)轴促成免疫逃逸和恶性进展。
Cell Death Dis. 2025 Jun 17;16(1):453. doi: 10.1038/s41419-025-07771-1.
3
Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target.
中期因子信号通路在女性癌症中的意义:新型生物标志物与治疗靶点
Int J Mol Sci. 2025 May 17;26(10):4809. doi: 10.3390/ijms26104809.
4
Elevated Midkine Serum Levels Are Associated with Long-Term Survival in Critically Ill Patients.危重症患者血清中期因子水平升高与长期生存相关。
Int J Mol Sci. 2023 Dec 29;25(1):454. doi: 10.3390/ijms25010454.
5
The role of midkine in health and disease.中期因子在健康和疾病中的作用。
Front Immunol. 2023 Nov 30;14:1310094. doi: 10.3389/fimmu.2023.1310094. eCollection 2023.
6
Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19.鼻咽战场:中期因子在鼻咽癌和新冠肺炎中介导的细胞免疫反应
Cancers (Basel). 2023 Oct 4;15(19):4850. doi: 10.3390/cancers15194850.
7
Midkine-A novel player in cardiovascular diseases.中期因子——心血管疾病中的新角色。
Front Cardiovasc Med. 2022 Sep 20;9:1003104. doi: 10.3389/fcvm.2022.1003104. eCollection 2022.
8
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.新型纳米技术方法克服肝癌治疗中的药物耐药性:Glypican 3 作为创新疗法的有用靶点。
Int J Mol Sci. 2022 Sep 2;23(17):10038. doi: 10.3390/ijms231710038.
9
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.治疗性癌症疫苗——抗原发现与佐剂递送平台
Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448.
10
Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma.丛状神经纤维瘤NF1患者中雌激素诱导生长因子中期因子和碱性成纤维细胞生长因子2的血清浓度升高。
Am J Transl Res. 2022 May 15;14(5):3180-3188. eCollection 2022.